01 1BCN Peptides
01 1ICATIBANT ACETATE
01 1Spain
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-09-21
Pay. Date : 2015-04-28
DMF Number : 29213
Submission : 2015-03-26
Status : Active
Type : II
20
Bcn Peptides Sa, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ICATIBANT ACETATE, with a corresponding US DMF Number 29213.
Remarkably, this DMF maintains an Active status since its submission on March 26, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2015, and payment made on April 28, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
